Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 189 Records) |
| Query Trace: Lymphoma and TP53[original query] |
|---|
| Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 9 100323. Claudio Agostinelli, Luca Morandi, Simona Righi, Luigi Cirillo, Marica Iommi, Caterina Tonon, Diego Mazzatenta, Matteo Zoli, Maura Rossi, Gianmarco Bagnato, Alessandro Broccoli, Raffaele Lodi, Pier Luigi Zinzani, Elena Sabattini, Caterina Giannini, Sofia Asio |
| Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma. Leukemia & lymphoma 2023 9 1-11. Andrew Ip, Alessandra Petrillo, Alexandra Della Pia, Geeny G Lee, Sarvarinder Gill, Tony Varughese, Joshua Zenreich, Martin Gutierrez, Jiayu Zhang, Jaeil Ahn, Vishnu Bharani, Ava S Nejad, Lauren Pascual, Tatyana A Feldman, Lori A Leslie, Andre H G |
| Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma. Annals of hematology 2023 9 . Osama Abd El Hameed Ebid, Lobna R Ezz El Arab, Amr S Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swell |
| Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. Cancer cell international 2023 8 23 (1): 187. Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo, Fang Wa |
| Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 8 . Luis Lara-Mejía, Andrés F Cardona, Luis Mas, Claudio Martín, Suraj Samtani, Luis Corrales, Graciela Cruz-Rico, Jordi Remon, Marco Galvez-Nino, Rossana Ruiz, Eduardo Rios-Garcia, Fernanda Tejada, Natalia Lozano-Vazquez, Rafael Rosell, Oscar Arrie |
| Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis (Alliance A151303). Blood advances 2023 7 . David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P Watkins, Felicia Gomez, Zachary L Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Nancy L Bartlett, Juan Pablo Alderuccio, Izidore S Lossos, Sarah L Ondrejka, Eric D Hsi, Peter Martin, John P Leonard, Malachi Griffith, Obi L Griffith, Todd A Fehnig |
| Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma. Blood advances 2023 6 . W Richard Burack, Hongli Li, Diana G Adlowitz, Janice M Spence, Lisa M Rimsza, Mazyar Shadman, Catherine Spier, Mark S Kaminski, John P Leonard, Michael Leblanc, Sonali M Smith, Jonathan W Friedbe |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
| TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy. Blood advances 2023 4 . William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E Lewis, Andrew D Zelenetz, M Lia Palomba, Matthew J Matasar, Ariela Noy, Audrey M Hamilton, Paul A Hamlin, Philip C Caron, David J Straus, Andrew M Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N Owens, Craig S Sauter, Lorenzo Falchi, Jennifer K Lue, Santosha A Vardhana, Gilles A Salles, Ahmet Dogan, Nikolaus D Schultz, Maria E Arcila, Steven M Horwi |
| MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
| Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
| Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar. Acta haematologica 2023 3 . Awata-Shiraiwa Maaya, Yokohama Akihiko, Kanai Yukihiro, Gotoh Nanami, Kasamatsu Tetsuhiro, Handa Hiroshi, Saitoh Takayuki, Murakami Hirokazu, Hirato Junko, Ikota Hayato, Tsukamoto Norifu |
| Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. Human genomics 2023 2 17 (1): 13. Yun Jiwon, Song Hyojin, Kim Sung-Min, Kim Soonok, Kwon Seok Ryun, Lee Young Eun, Jeong Dajeong, Park Jae Hyeon, Kwon Sunghoon, Yun Hongseok, Lee Dong So |
| Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 12 JCO2301053. Daniel Noerenberg, Franziska Briest, Cornelius Hennch, Kenichi Yoshida, Raphael Hablesreiter, Yasuhide Takeuchi, Hiroo Ueno, Annette M Staiger, Marita Ziepert, Fazila Asmar, Benjamin N Locher, Erika Toth, Thomas Weber, Rose-Marie Amini, Wolfram Klapper, Maria Bouzani, Viola Poeschel, Andreas Rosenwald, Gerhard Held, Elías Campo, Naveed Ishaque, Kostas Stamatopoulos, George Kanellis, Ioannis Anagnostopoulos, Lars Bullinger, Neta Goldschmidt, Pier Luigi Zinzani, Csaba Bödör, Richard Rosenquist, Theodoros P Vassilakopoulos, German Ott, Seishi Ogawa, Frederik Da |
| The genetic landscape of histologically transformed marginal zone lymphomas. Cancer 2023 11 . Anqi Li, Hongmei Yi, Shijie Deng, Miao Ruan, Pengpeng Xu, Yujia Huo, Haiyang Lu, Xia Shen, Binsen Ouyang, Mingci Cai, Haimin Xu, Zhongyu Wang, Lei Zhang, Lingyan Zhu, Qi Peng, Yijin Gu, Jialing Xie, Yan Wang, Lei Dong, Zebing Liu, Chaofu Wa |
| Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. HemaSphere 2023 11 7 (11): e976. Madeleine R Berendsen, Diede A G van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Annemiek B van Spriel, Ellen van der Spek, Johannes F M Pruijt, Leonie I Kroeze, Konnie M Hebeda, Sandra Croockewit, Wendy B C Stevens, J Han J M van Krieken, Patricia J T A Groenen, Michiel van den Brand, Blanca Scheij |
| Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group. Haematologica 2023 11 . Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Selim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joel Fleury, Fabrice Jardin, Clementine Sarkozy, Ghandi Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cecile Chabrot, Veronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Reda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morineau, Marie Pierre Moles, Hacene Zerazhi, Jean Fontan, Yazid Arkam, Magda Alexis, Vincent Delwail, Jean Pierre Vilque, Loic Ysebaert, Barbara Burroni, Mary Callanan, Steven Le Gouill, Rémy Gress |
| Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. Cancer cell international 2023 11 23 (1): 281. Yang Li, Yang Liu, Keyan Yang, Ling Jin, Jing Yang, Shuang Huang, Ying Liu, Bo Hu, Rong Liu, Wei Liu, Ansheng Liu, Qinlong Zheng, Yonghong Zha |
| Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine 2023 10 64 102221. Urban Novak, Martin Fehr, Sämi Schär, Martin Dreyling, Christian Schmidt, Enrico Derenzini, Thilo Zander, Georg Hess, Ulrich Mey, Simone Ferrero, Nicolas Mach, Carola Boccomini, Sebastian Böttcher, Michèle Voegeli, Anne Cairoli, Vanesa-Sindi Ivanova, Thomas Menter, Stefan Dirnhofer, Bernhard Scheibe, Sandra Gadient, Katrin Eckhardt, Emanuele Zucca, Christoph Driessen, Christoph Renn |
| TP53 mutations predict for poor outcomes in patients with newly-diagnosed aggressive B cell lymphomas in the current era. Blood advances 2023 10 . Daniel J Landsburg, Jennifer Jd Morrissette, Sunita D Nasta, Stefan K Barta, Stephen J Schuster, Jakub Svoboda, Elise A Chong, Adam Ba |
| Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 2023 1 . Michot Jean-Marie, Quivoron Cyril, Sarkozy Clémentine, Danu Alina, Lazarovici Julien, Saleh Khalil, El-Dakdouki Yolla, Goldschmidt Vincent, Bigenwald Camille, Dragani Matteo, Bahleda Rastislav, Baldini Capucine, Arfi-Rouche Julia, Martin-Romano Patricia, Tselikas Lambros, Gazzah Anas, Hollebecque Antoine, Lacroix Ludovic, Ghez David, Vergé Veronique, Marzac Christophe, Cotteret Sophie, Rahali Wassila, Soria Jean-Charles, Massard Christophe, Bernard Olivier A, Dartigues Peggy, Camara-Clayette Valérie, Ribrag Vince |
| [Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (12): 1010-1015. Shi Y F, Gao Z F, Li X H, Guo L G, Zheng Q L, Long M P, Deng L J, Du T T, Jia L, Zhao W, Song X X, Li |
| Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients. Clinical laboratory 2023 1 69 (1): . Wang HongBiao, Lin YingCheng, Li ZhiFeng, Wu YueRong, Yang ZhengYuan, Gao ShiHua, Lin FangFa |
| Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL. Annals of hematology 2024 8 . Mutibaier Mijiti, Chun Wang, Wenxin Tian, Qiping Shi, Fang Zhang, Renaguli Abulaiti, Xiaolong Qi, Zhen Kou, Cuicui Liu, Zengsheng Wang, Shunsheng Zhai, Li An, Qin Huang, Yang Shao, Guzailinuer Wufuer, Yan |
| Single nucleotide polymorphism profiles of canine T-cell and null-cell lymphomas. Frontiers in veterinary science 2024 8 11 1439706. Sirintra Sirivisoot, Tanit Kasantikul, Somporn Techangamsuwan, Anudep Rungsipip |
| Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients. Cancer drug resistance (Alhambra, Calif.) 2024 6 7 21. Gabriele Perrone, Luigi Rigacci, Giandomenico Roviello, Ida Landini, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo, Monica Bocchia, Alberto Bosi, Enrico Mini, Stefania Nobi |
| Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE. Annals of hematology 2024 6 . Keshu Zhou, Tingyu Wang, Ling Pan, Wei Xu, Jie Jin, Wei Zhang, Yu Hu, Jianda Hu, Ru Feng, Ping Li, Zhougang Liu, Peng Liu, Hongmei Jing, Sujun Gao, Huilai Zhang, Kang Yu, Zhao Wang, Xiongpeng Zhu, Zimin Sun, Fei Li, Dongmei Yan, Jianyu Weng, Lina Fu, Liping Wang, Tommi Salmi, Kenneth Wu, Lugui Q |
| Genomic landscape and distinct molecular subtypes of primary testicular lymphoma. Journal of translational medicine 2024 5 22 (1): 414. Weilong Zhang, Ping Yang, Yaru Yang, Shuozi Liu, Yongdeng Xu, Chaoling Wu, Jing Wang, Cuiling Liu, Hui Liu, Shuangshuang Li, Wei Huang, Hongmei Ji |
| Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma. JAMA dermatology 2024 1 . Noreen Mohsin, Devin Hunt, Jia Yan, Austin J Jabbour, Paul Nghiem, Jaehyuk Choi, Yue Zhang, Alexandra F Freeman, Jenna R E Bergerson, Stefania Dell'Orso, Kristina Lachance, Rima Kulikauskas, Loren Collado, Wenjia Cao, Justin Lack, Morgan Similuk, Bryce A Seifert, Rajarshi Ghosh, Magdalena A Walkiewicz, Isaac Browne |
| Genetic and prognostic analysis of blastoid and pleomorphic mantle cell lymphoma: a multicenter analysis in China. Annals of hematology 2024 1 . Ping Yang, Shuo-Zi Liu, Chun-Yuan Li, Wei-Long Zhang, Jing Wang, Ying-Tong Chen, Sen Li, Cui-Ling Liu, Hui Liu, Qing-Qing Cai, Wei Zhang, Hong-Mei Ji |
- Page last reviewed:Feb 1, 2024
- Content source: